Can't find or afford Quviviq? Learn about alternative insomnia medications including Belsomra, Dayvigo, Ambien, and Lunesta — how they compare and what to ask your doctor.
Quviviq (Daridorexant) has become a popular choice for treating insomnia, thanks to its unique mechanism of action and favorable side effect profile. But finding it in stock or getting it covered by insurance can be a real challenge.
If you've been prescribed Quviviq but can't fill your prescription — whether because of availability, cost, or insurance issues — you have options. In this post, we'll look at what Quviviq is, how it works, and the best alternative medications to discuss with your doctor.
Quviviq is a dual orexin receptor antagonist (DORA) approved by the FDA in 2022 for treating insomnia in adults. It works by blocking orexin, a brain chemical that promotes wakefulness. By reducing the brain's wake signals, Quviviq helps you fall asleep and stay asleep more naturally.
This is fundamentally different from older sleep medications like benzodiazepines and Z-drugs, which work by enhancing GABA — a chemical that sedates the brain. Quviviq's approach means it doesn't produce the same kind of heavy sedation, and it carries a lower risk of dependence compared to many older options.
For a deeper dive into how the drug works, see our post: How Does Quviviq Work? Mechanism of Action Explained.
There are several common reasons patients end up looking for Quviviq alternatives:
Belsomra was the first dual orexin receptor antagonist approved by the FDA, back in 2014. Like Quviviq, it blocks orexin receptors to reduce wakefulness.
Key details:
How it compares to Quviviq: Belsomra works through the same mechanism but has a longer half-life, which may increase the risk of next-day drowsiness. Clinical studies suggest Quviviq may have a slight edge in improving daytime functioning, but both are effective for insomnia.
Dayvigo is another DORA, approved by the FDA in 2019. It is slightly more selective for the orexin-2 (OX2) receptor compared to the orexin-1 (OX1) receptor.
Key details:
How it compares to Quviviq: Dayvigo has a significantly longer half-life, which can be beneficial for sleep maintenance but may increase next-morning drowsiness. Some insurance plans may cover Dayvigo more readily than Quviviq, or vice versa — it's worth checking with your plan.
Ambien is one of the most well-known insomnia medications. It's a Z-drug that works on GABA receptors — a completely different mechanism from Quviviq.
Key details:
How it compares to Quviviq: Zolpidem is much cheaper and more widely available, but it works through a fundamentally different mechanism. It tends to be more effective for sleep onset but less effective for sleep maintenance. It also carries a higher risk of complex sleep behaviors, dependence, and rebound insomnia.
Lunesta is another Z-drug that modulates GABA receptors. It was approved by the FDA in 2004.
Key details:
How it compares to Quviviq: Eszopiclone can help with both sleep onset and sleep maintenance due to its longer half-life compared to Zolpidem. It's much more affordable, but like Zolpidem, it works through GABA modulation and carries a higher risk of dependence and next-day impairment.
The best alternative depends on your specific situation:
Always talk to your doctor before switching medications. They can consider your full medical history, other medications you take (see our post on Quviviq drug interactions), and your specific sleep challenges.
Not being able to fill your Quviviq prescription is frustrating, but you're not out of options. Before switching, though, make sure you've explored all avenues for finding Quviviq — tools like Medfinder can help you locate it at a pharmacy near you. And if cost is the issue, check out our guide on saving money on Quviviq.
If you do need to switch, rest assured that there are effective alternatives available. Work with your doctor to find the one that best fits your needs.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
